ArticleActa pharmaceutica Sinica. B2021

Ligand-based substituent-anchoring design of selective receptor-interacting protein kinase 1 necroptosis inhibitors for ulcerative colitis therapy.

Jing Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.